Navigation Links
Eurand Announces Positive Phase III Clinical Study Results

ars) and an older patient population.

Study results showed a clinically and statistically significant increase in the coefficient of fat absorption (CFA) in patients treated with Zentase. The mean percentage of CFA in patients receiving Zentase was 88.3 percent versus 62.8 percent in patients receiving placebo (p<0.001). Treatment guidelines suggest that the CFA should be at least 85 percent in cystic fibrosis (CF) patients(3).

"The protocols for these trials were reviewed by the FDA and developed in collaboration with the Cystic Fibrosis Foundation (CFF). We want to thank the CFF for their support," added Faherty.

Phase III Pivotal Study Results

This randomized, double-blind, placebo-controlled, cross-over study evaluated CF patients with EPI aged seven years and older. Patients treated with Zentase showed a statistically significant increase in the coefficient of fat absorption and coefficient of nitrogen absorption (CNA) as compared to those receiving a placebo. They also had fewer symptoms associated with impaired absorption such as bloating, flatulence, pain and evidence of fat in stools.

Moreover, in all study patients, regardless of starting levels while taking placebo, Zentase returned CFA and CNA absorption levels to ranges considered normal in healthy patients. We believe this suggests Zentase can provide the level of enzyme supplementation required by cystic fibrosis patients with different levels of EPI.

"I believe the results of this successful trial demonstrated the efficacy and safety of Zentase," said James E. Heubi, MD, Professor and Associate Chair for Clinical Research of Pediatrics at Children's Hospital Medical Center in Cincinnati, OH. "During the study, the level of fat absorption achieved with Zentase was very high and close to levels seen in healthy patients, even without the use of proton pump inhibitors (PPIs). This high fat absorption, without relying on PPIs could significantly reduce the number
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
2. Eurand to Present Zentase Phase III Data
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Eurand Announces Positive Phase III Clinical Study Results
(Date:5/23/2013)...  Texas, premier physician associations today announced the establishment ... they need to provide demonstrably better and more efficient ... "I am confident the Physician Services Organization ... Stephen L. Brotherton , MD, president of ... doctors are determined to make health care better ...
(Date:5/23/2013)... 2013  Net Medical Xpress Solutions, Inc., (OTC QB: ... the company has signed a letter of intent to ... Huntsville, AL . MedTel Solutions is ... and recruitment of telemedicine physicians. Consideration for the acquisition ... which is expected by June 30, 2013. ...
(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... )     "With his established financial management ... gained by working in our commercial group for ...
Breaking Medicine Technology:TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2
... Minn., Sept. 25 CSL Plasma , one of ... from the Duluth area today as part of a statewide ... to Randy Furby, Senior Vice President and General Manager of ... raise awareness of rare genetic diseases treated with plasma-derived therapies ...
... Hologic, Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and surgical ... announced that the Radiological Devices Panel (Panel) of the ... that Hologic,s Pre-Market Approval (PMA) demonstrated both the effectiveness ...
Cached Medicine Technology:Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases 2Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 2Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 3Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel 4
(Date:5/24/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... children than adults, with signs of serious complications seen ... "Based on the latest results, it seems ... said Dr. Jane Chiang, senior vice president of medical ... "Complications are appearing faster, and it appears to be ...
(Date:5/24/2013)... Nearly three out of four pregnant women experience ... these issues don,t significantly affect their quality of ... Loyola University Medical Center in Maywood, Ill., noted ... and hormonal changes that occur during pregnancy. Nutritional ... play a role. The study authors added that ...
(Date:5/24/2013)... MonaVie announces the appointment of Mauricio Patrocinio, vice ... the Ethics Board of ABEVD (Brazilian Association of Direct Sales ... this council and will do my best to promote and ... Patrocinio. , The direct selling industry is booming in Brazil ... selling industry has, for decades, helped improve the lives of ...
(Date:5/24/2013)... to the new market research report “Micro Irrigation System ... by MarketsandMarkets, global micro irrigation system market expected to ... 2010 and is expected to reach $3,414.7 million by ... to 2016. , Browse:, , 150 ... 370 pages and in-depth Table Of Content ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Child safety ... seven tips for end-of-year gifts for teachers that can ... a child's life." Van der Zande is the founder ... education and resources, whose mission is to help people ... , "Teachers have an incredible impact on the ...
Breaking Medicine News(10 mins):Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 4
... Boston Scientific Corporation (NYSE: BSX ) today announced financial results ... for net sales and earnings per share (EPS) for the second quarter ... growth rates are constant currency): , , ... EPS of $0.19, both in line with guidance (GAAP loss per share ...
... should start with "evidence-based reimbursement", structuring physician payment ... which would improve quality and reduce the cost ... cardiologists and published in Circulation: Cardiovascular Quality ... example, some 500,000 U.S. patients suffering from mild ...
... San Diego was named a 2009 Clean Air Circle Honoree ... their annual Evening in the Sky Gala. Waste Management ... clean and ongoing efforts to protect the environment and promote ... working to promote clean air throughout San Diego, especially as ...
... needed economic boost to primary care services for Floridians ... Speaker Nancy Pelosi joined Rep. Debbie Wasserman Schultz today ... discuss the positive impact of the American Recovery and ... $10 million in federal stimulus money to fund eight ...
... glucose-based beverages may not have same impact, study finds ... drinks and other beverages can have a negative effect ... to handle fats, increasing the risk of heart attack ... glucose-sweetened beverages don,t have that kind of impact, the ...
... limits of procedure, study suggests , , MONDAY, April 20 ... removal of certain head and neck cancers, U.S. researchers ... cavity, throat or larynx tumors. Of those patients, 29 ... cancerous tissue. Negative margins (when no cancer cells are ...
Cached Medicine News:Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 2Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 3Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 4Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 5Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 6Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 7Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 8Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 9Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 10Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 11Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 12Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 13Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 14Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 15Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 16Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 17Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 18Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 19Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 20Health News:Boston Scientific Announces Results For First Quarter Ended March 31, 2009 21Health News:Health-care reform should start with paying evidence-based financial incentives to doctors 2Health News:Waste Management Honored by American Lung Association for Environmental Achievements 2Health News:Speaker Pelosi Visits Florida Health Center 2Health News:Robotic Surgery Practical for Some Head, Neck Tumors 2
This revolutionary system combines the CSZ Head Wrap and Patient Vest for a non-invasive whole body hypothermia system. This method of cooling the patient allows for early treatment that is fast, cos...
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Medicine Products: